K+S Aktiengesellschaft (LON:0Q2N)
12.01
+0.35 (2.99%)
At close: Dec 5, 2025
K+S Aktiengesellschaft Revenue
K+S Aktiengesellschaft had revenue of 879.10M EUR in the quarter ending September 30, 2025, with 1.49% growth. This brings the company's revenue in the last twelve months to 3.64B, down -1.67% year-over-year. In the year 2024, K+S Aktiengesellschaft had annual revenue of 3.65B, down -5.67%.
Revenue (ttm)
3.64B EUR
Revenue Growth
-1.67%
P/S Ratio
0.59
Revenue / Employee
335.96K EUR
Employees
10,835
Market Cap
1.86B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.65B | -219.50M | -5.67% |
| Dec 31, 2023 | 3.87B | -1.80B | -31.78% |
| Dec 31, 2022 | 5.68B | 2.46B | 76.67% |
| Dec 31, 2021 | 3.21B | 781.00M | 32.11% |
| Dec 31, 2020 | 2.43B | -117.60M | -4.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |